A new option for erectile dysfunction (ED) sufferers will soon be hitting store shelves, no prescription needed. Drug company Futura Medical announced the Food and Drug Administration’s (FDA) approval ...
The test ran over four weeks, with 112 subjects using Eroxon and 111 testing the Intense formula. Participants reported satisfaction with erection hardness in 70% of sexual encounters using Eroxon and ...
Futura Medical plc (AIM: FUM), the consumer healthcare company behind Eroxon® and that specialises in the development and global commercialisation of innovative and clinically proven sexual health ...
UNITED KINGDOM - Futura Medical plc (AIM:FUM) announced results from a home user test comparing its Eroxon gel for erectile dysfunction with a new prototype formula called Eroxon Intense, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results